Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Premedication for ESD Satisfaction
NCT02504164Completed
- Sponsor
- Yonsei University
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in gastric cancer (GC) and gastric adenoma (2 arms), sponsored by Yonsei University. Primary endpoints: Overall patient satisfaction scores, Willingness to receive same method of sedation and 2 more. Started Sep 2014; status: completed.
02
Drugs
midazolam
03
Conditions
gastric cancer (GC)gastric adenoma
Beyond the preview
Go deeper on NCT02504164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504164.